Nilanjan Ghosh

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Topic:
    CLL, Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    CLL, Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Beigene
    Topic:
    CLL, Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    CLL, Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech/Roche
    Topic:
    Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    CLL, Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite/Gilead
    Topic:
    Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Incyte
    Topic:
    Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Galapagos
    Topic:
    Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ascentage Pharma
    Topic:
    Lymphoma
    Date added:
    03/25/2025
    Date updated:
    03/25/2025

Pages

Return to North Carolina Hematologic Malignancies Symposium